Report Detail
Global Neuropathic Eye Pain Market Growth (Status and Outlook) 2023-2029
- RnM4532971 |
- 30 May, 2023 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Medical Industry
The global Neuropathic Eye Pain market size is projected to grow from US$ 148.7 million in 2022 to US$ 186 million in 2029; it is expected to grow at a CAGR of 3.2% from 2023 to 2029.
United States market for Neuropathic Eye Pain is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neuropathic Eye Pain is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neuropathic Eye Pain is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neuropathic Eye Pain players cover OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated and Kala Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Neuropathic Eye Pain Industry Forecast” looks at past sales and reviews total world Neuropathic Eye Pain sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuropathic Eye Pain sales for 2023 through 2029. With Neuropathic Eye Pain sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuropathic Eye Pain industry.
This Insight Report provides a comprehensive analysis of the global Neuropathic Eye Pain landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuropathic Eye Pain portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuropathic Eye Pain market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuropathic Eye Pain and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuropathic Eye Pain.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuropathic Eye Pain market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Steroids
Antidepressants
Anticonvulsants
Opioids
Others
Segmentation by application
Clinic
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
OKYO Pharma
Ocular Therapeutix, Inc.
IACTA Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Ltd
Novartis AG
SALVAT
AbbVie Inc
Bausch &Lomb Incorporated
Kala Pharmaceuticals
Spectra Vision Care
AlconLaboratories
BRIM Biotechnology Inc
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Neuropathic Eye Pain Market Size 2018-2029
- 2.1.2 Neuropathic Eye Pain Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Neuropathic Eye Pain Segment by Type
- 2.2.1 Steroids
- 2.2.2 Antidepressants
- 2.2.3 Anticonvulsants
- 2.2.4 Opioids
- 2.2.5 Others
- 2.3 Neuropathic Eye Pain Market Size by Type
- 2.3.1 Neuropathic Eye Pain Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Neuropathic Eye Pain Market Size Market Share by Type (2018-2023)
- 2.4 Neuropathic Eye Pain Segment by Application
- 2.4.1 Clinic
- 2.4.2 Hospital
- 2.4.3 Others
- 2.5 Neuropathic Eye Pain Market Size by Application
- 2.5.1 Neuropathic Eye Pain Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Neuropathic Eye Pain Market Size Market Share by Application (2018-2023)
3 Neuropathic Eye Pain Market Size by Player
- 3.1 Neuropathic Eye Pain Market Size Market Share by Players
- 3.1.1 Global Neuropathic Eye Pain Revenue by Players (2018-2023)
- 3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Players (2018-2023)
- 3.2 Global Neuropathic Eye Pain Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Neuropathic Eye Pain by Regions
- 4.1 Neuropathic Eye Pain Market Size by Regions (2018-2023)
- 4.2 Americas Neuropathic Eye Pain Market Size Growth (2018-2023)
- 4.3 APAC Neuropathic Eye Pain Market Size Growth (2018-2023)
- 4.4 Europe Neuropathic Eye Pain Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Neuropathic Eye Pain Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Neuropathic Eye Pain Market Size by Country (2018-2023)
- 5.2 Americas Neuropathic Eye Pain Market Size by Type (2018-2023)
- 5.3 Americas Neuropathic Eye Pain Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Neuropathic Eye Pain Market Size by Region (2018-2023)
- 6.2 APAC Neuropathic Eye Pain Market Size by Type (2018-2023)
- 6.3 APAC Neuropathic Eye Pain Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Neuropathic Eye Pain by Country (2018-2023)
- 7.2 Europe Neuropathic Eye Pain Market Size by Type (2018-2023)
- 7.3 Europe Neuropathic Eye Pain Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Neuropathic Eye Pain by Region (2018-2023)
- 8.2 Middle East & Africa Neuropathic Eye Pain Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Neuropathic Eye Pain Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Neuropathic Eye Pain Market Forecast
- 10.1 Global Neuropathic Eye Pain Forecast by Regions (2024-2029)
- 10.1.1 Global Neuropathic Eye Pain Forecast by Regions (2024-2029)
- 10.1.2 Americas Neuropathic Eye Pain Forecast
- 10.1.3 APAC Neuropathic Eye Pain Forecast
- 10.1.4 Europe Neuropathic Eye Pain Forecast
- 10.1.5 Middle East & Africa Neuropathic Eye Pain Forecast
- 10.2 Americas Neuropathic Eye Pain Forecast by Country (2024-2029)
- 10.2.1 United States Neuropathic Eye Pain Market Forecast
- 10.2.2 Canada Neuropathic Eye Pain Market Forecast
- 10.2.3 Mexico Neuropathic Eye Pain Market Forecast
- 10.2.4 Brazil Neuropathic Eye Pain Market Forecast
- 10.3 APAC Neuropathic Eye Pain Forecast by Region (2024-2029)
- 10.3.1 China Neuropathic Eye Pain Market Forecast
- 10.3.2 Japan Neuropathic Eye Pain Market Forecast
- 10.3.3 Korea Neuropathic Eye Pain Market Forecast
- 10.3.4 Southeast Asia Neuropathic Eye Pain Market Forecast
- 10.3.5 India Neuropathic Eye Pain Market Forecast
- 10.3.6 Australia Neuropathic Eye Pain Market Forecast
- 10.4 Europe Neuropathic Eye Pain Forecast by Country (2024-2029)
- 10.4.1 Germany Neuropathic Eye Pain Market Forecast
- 10.4.2 France Neuropathic Eye Pain Market Forecast
- 10.4.3 UK Neuropathic Eye Pain Market Forecast
- 10.4.4 Italy Neuropathic Eye Pain Market Forecast
- 10.4.5 Russia Neuropathic Eye Pain Market Forecast
- 10.5 Middle East & Africa Neuropathic Eye Pain Forecast by Region (2024-2029)
- 10.5.1 Egypt Neuropathic Eye Pain Market Forecast
- 10.5.2 South Africa Neuropathic Eye Pain Market Forecast
- 10.5.3 Israel Neuropathic Eye Pain Market Forecast
- 10.5.4 Turkey Neuropathic Eye Pain Market Forecast
- 10.5.5 GCC Countries Neuropathic Eye Pain Market Forecast
- 10.6 Global Neuropathic Eye Pain Forecast by Type (2024-2029)
- 10.7 Global Neuropathic Eye Pain Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 OKYO Pharma
- 11.1.1 OKYO Pharma Company Information
- 11.1.2 OKYO Pharma Neuropathic Eye Pain Product Offered
- 11.1.3 OKYO Pharma Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 OKYO Pharma Main Business Overview
- 11.1.5 OKYO Pharma Latest Developments
- 11.2 Ocular Therapeutix, Inc.
- 11.2.1 Ocular Therapeutix, Inc. Company Information
- 11.2.2 Ocular Therapeutix, Inc. Neuropathic Eye Pain Product Offered
- 11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Ocular Therapeutix, Inc. Main Business Overview
- 11.2.5 Ocular Therapeutix, Inc. Latest Developments
- 11.3 IACTA Pharmaceuticals, Inc.
- 11.3.1 IACTA Pharmaceuticals, Inc. Company Information
- 11.3.2 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product Offered
- 11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 IACTA Pharmaceuticals, Inc. Main Business Overview
- 11.3.5 IACTA Pharmaceuticals, Inc. Latest Developments
- 11.4 Sun Pharmaceutical Industries Ltd
- 11.4.1 Sun Pharmaceutical Industries Ltd Company Information
- 11.4.2 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product Offered
- 11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Sun Pharmaceutical Industries Ltd Main Business Overview
- 11.4.5 Sun Pharmaceutical Industries Ltd Latest Developments
- 11.5 Novartis AG
- 11.5.1 Novartis AG Company Information
- 11.5.2 Novartis AG Neuropathic Eye Pain Product Offered
- 11.5.3 Novartis AG Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Novartis AG Main Business Overview
- 11.5.5 Novartis AG Latest Developments
- 11.6 SALVAT
- 11.6.1 SALVAT Company Information
- 11.6.2 SALVAT Neuropathic Eye Pain Product Offered
- 11.6.3 SALVAT Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 SALVAT Main Business Overview
- 11.6.5 SALVAT Latest Developments
- 11.7 AbbVie Inc
- 11.7.1 AbbVie Inc Company Information
- 11.7.2 AbbVie Inc Neuropathic Eye Pain Product Offered
- 11.7.3 AbbVie Inc Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 AbbVie Inc Main Business Overview
- 11.7.5 AbbVie Inc Latest Developments
- 11.8 Bausch &Lomb Incorporated
- 11.8.1 Bausch &Lomb Incorporated Company Information
- 11.8.2 Bausch &Lomb Incorporated Neuropathic Eye Pain Product Offered
- 11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Bausch &Lomb Incorporated Main Business Overview
- 11.8.5 Bausch &Lomb Incorporated Latest Developments
- 11.9 Kala Pharmaceuticals
- 11.9.1 Kala Pharmaceuticals Company Information
- 11.9.2 Kala Pharmaceuticals Neuropathic Eye Pain Product Offered
- 11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Kala Pharmaceuticals Main Business Overview
- 11.9.5 Kala Pharmaceuticals Latest Developments
- 11.10 Spectra Vision Care
- 11.10.1 Spectra Vision Care Company Information
- 11.10.2 Spectra Vision Care Neuropathic Eye Pain Product Offered
- 11.10.3 Spectra Vision Care Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Spectra Vision Care Main Business Overview
- 11.10.5 Spectra Vision Care Latest Developments
- 11.11 AlconLaboratories
- 11.11.1 AlconLaboratories Company Information
- 11.11.2 AlconLaboratories Neuropathic Eye Pain Product Offered
- 11.11.3 AlconLaboratories Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 AlconLaboratories Main Business Overview
- 11.11.5 AlconLaboratories Latest Developments
- 11.12 BRIM Biotechnology Inc
- 11.12.1 BRIM Biotechnology Inc Company Information
- 11.12.2 BRIM Biotechnology Inc Neuropathic Eye Pain Product Offered
- 11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 BRIM Biotechnology Inc Main Business Overview
- 11.12.5 BRIM Biotechnology Inc Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Neuropathic Eye Pain. Industry analysis & Market Report on Neuropathic Eye Pain is a syndicated market report, published as Global Neuropathic Eye Pain Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Neuropathic Eye Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
